Restoring the guardian of the genome

The unmutated, or wild-type, version of the gene, which was cloned from humans and mice in the 1980s, exerted the exact opposite effect: the gene acted as a potent inhibitor of tumorigenesis (S. J. Baker et al. Environmental stress, abnormal metabolic activity, genetic damage and advanced ageing can...

Full description

Saved in:
Bibliographic Details
Published inNature (London) Vol. 603; no. 7899; p. S1
Main Author Eisenstein, Michael
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group 03.03.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The unmutated, or wild-type, version of the gene, which was cloned from humans and mice in the 1980s, exerted the exact opposite effect: the gene acted as a potent inhibitor of tumorigenesis (S. J. Baker et al. Environmental stress, abnormal metabolic activity, genetic damage and advanced ageing can all trigger the protein's activation, enabling p53 to directly regulate the expression of hundreds of genes to initiate an appropriate response. Cell Death Differ. 25, 154-160; 2018), and nearly 90% of people born with such mutations - a rare hereditary condition known as Li-Fraumeni Syndrome - will develop cancer in their lifetime.
ISSN:0028-0836
1476-4687
DOI:10.1038/d41586-022-00565-x